beta-L-hydroxycytosine nucleosides (Max Delbruck Centrum)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namebeta-L-hydroxycytosine nucleosides (Max Delbruck Centrum)
Drug Alias Namebeta-L-Hyd4Cbeta-L-deoxycytidine derivatives (Max Delbruck Centrum/Ascenion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMax Delbruck Centrum Fur Molekulare Medizin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMax Delbruck Centrum Fur Molekulare MedizinAscenion
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A